Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06050304

CRACK-TARGET 1: Descriptive Study of Observed Behavioral Sensitization and Expectations

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-01-15

20

Participants Needed

2

Research Sites

52 weeks

Total Duration

On this page

Sponsors

A

Assistance Publique - Hôpitaux de Paris

Lead Sponsor

I

Institut National de la Santé Et de la Recherche Médicale, France

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research focuses on behavioral sensitization (BS) a specific behavioural disturbance in crack-cocaine addiction. The primary objective is to observe whether BS can be demonstrated in an ecological setting in crack dependent users by continuous actimetry for 3 weeks. It is planned to include 20 persons with a current crack-cocaine addiction with a preferential use of rapid administration route (intravenous or smoke), in a care institution: Fernand Widal Hospital. In the proposed research, the investigators will assess the movements of crack-cocaine dependent users in relation to consumption. They will have to wear continuously for 3 weeks an actimeter. They will also have 3 blood tests trying to identify biomarkers of BS.

CONDITIONS

Official Title

CRACK-TARGET 1: Descriptive Study of Observed Behavioral Sensitization and Expectations

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age over 18 years
  • Current crack-cocaine use disorder defined as Severe Intensity Use Disorder (6 or more DSM5 criteria) with preferential use of rapid administration route (intravenous or smoked)
  • Self-identified male or female (10 males and 10 females planned)
  • Negative pregnancy test for females and use of effective contraception
  • Affiliated with a social security plan (or PUMA or CSS or AME)
  • Signed informed consent and commitment to 3-week follow-up
  • Weight greater than 40 kg
Not Eligible

You will not qualify if you...

  • Psychiatric disorder or symptoms that are not currently stabilized
  • Minor or under protective supervision (curatorship or guardianship)
  • In care at the request of a judicial authority (therapeutic injunction, classification with orientation)
  • Pregnant or breastfeeding women
  • Insufficient proficiency in French or English
  • Weight less than 40 kg

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Centre 001_Hôpital Fernand Widal

Paris, France, 75010

Actively Recruiting

2

Hôpital Fernand Widal

Paris, France, F75010

Actively Recruiting

Loading map...

Research Team

F

Florence Vorspan, MD, PhD

CONTACT

F

Florence Vorspan, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here